In Brief: Cold-Eeze in Canada
This article was originally published in The Tan Sheet
Executive Summary
Cold-Eeze in Canada: Genpharm, a subsidiary of Darmstadt, Germany-based Merck KGaA, obtains exclusive rights to market Quigley's Cold-Eeze zinc lozenge in Canada, Quigley announces Feb. 17. Cold-Eeze leads the zinc lozenge category in the U.S., according to the company, generating sales of $41 mil. through the first nine months of 1997...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning